Health

Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA

SINGAPORE, Oct. 26, 2023 /PRNewswire/ -- On October 26, 2023, Biosyngen's TIL therapy BST02 for liver cancer was granted an approval for clinical trial by the US FDA. BST02, a breakthrough product in the field of cell and gene therapy, represents the world's first TIL therapy designed for the tre...

2023-10-26 18:18 2615

World Psoriasis Day 2023: Access for All

STOCKHOLM, Oct. 26, 2023 /PRNewswire/ -- Every year on World Psoriasis Day, October 29th, the international psoriatic disease community unites to raise awareness and fight for progress. The theme of 2023, "Access for All," underscores the vital need for Universal Health Coverage (UHC) to ensure t...

2023-10-26 16:00 2020

'MAKE WAVES FOR HONG KONG' By Splash Foundation To be held on November 4th, 2023

Olympic Swimmers and Business Leaders to Race Around Hong Kong To Address City's Chronic Swim Illiteracy * 5 teams, comprising 30 elite swimmers and business leaders, to undertake challenging 45-kilometre relay swim aroundHong Kong Island * The swim is expected to take 11-13 hours starting in...

2023-10-26 14:00 1953

Prof. Yongmei Yin at 2023 ESMO: SKB264 (MK-2870), an innovativeTROP2-ADC originating from Chinese biotech, achieves remarkable success in overcoming the therapeutic impasse in HR+/HER2- metastatic breast cancer

CHENGDU, China, Oct. 26, 2023 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) convened its annual meeting inMadrid, Spain, from October 20th to 24th, 2023. As the preeminent academic gathering in the field ofoncology, it brought together global experts in oncology to share the la...

2023-10-26 12:58 2088

The International Diabetic Lower Extremity Symposium of the International Society of Regenerative Medicine and Wound Repair Held

PHUKET, Thailand, Oct. 26, 2023 /PRNewswire/ -- During the period from October 25 to 27, 2023, the International Diabetic Lower Extremity Symposium of the International Society of Regenerative Medicine and Wound Repair is held in Thailand. Over 200 experts and scholars from more than 20 countries ...

2023-10-26 10:29 1805

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer

JINAN, China, Oct. 25, 2023 /PRNewswire/ -- On October 22, Qilu Pharmaceutical unveiled the latest findings from a multicenter, single-arm Phase II clinical trial at the European Society for Medical Oncology (ESMO) Annual Congress 2023. This trial studied the use of QL1706 (iparomlimab and tuvonr...

2023-10-25 22:33 2075

FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic

* FDA INTERACT meeting reviews Turn Bio's ERA™ and eTurna™ technologies, approach and plans, paving way toward its IND * Company continues to pace industry's cell regeneration therapy progress MOUNTAIN VIEW, Calif., Oct. 25, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation compa...

2023-10-25 20:30 1784

ESAOTE's new S-scan Open redefines excellence in magnetic resonance imaging

GENOA, Italy, Oct. 25, 2023 /PRNewswire/ -- Esaote, a leading Italian company in ultrasound, dedicated MRI and healthcare IT,presents S-scan Open, the new configuration of S-scan,one of its best-selling MRI systems.  

2023-10-25 20:00 2301

NEWLY-LAUNCHED AMAZFIT ACTIVE AND AMAZFIT ACTIVE EDGE INTRODUCE A STYLISH WAY TO STAY ACTIVE & STAY HEALTHY

Tailored for the modern-day city consumer, the Amazfit Active and Amazfit Active Edge seamlessly blend style, functionality, and health, redefining what it means to live an active lifestyle. MILPITAS, Calif., Oct. 25, 2023 /PRNewswire/ -- Amazfit , a leading global smar...

2023-10-25 20:00 2150

Metabolon and Genomics England Announce Partnership to Characterize Hundreds of Rare Diseases and Advance Rare Disease Diagnosis

Alliance aims to enable the discovery of novel rare disease biomarkers to support faster diagnosis and more effective treatments MORRISVILLE, N.C., and LONDON, Oct. 25, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life sc...

2023-10-25 19:57 1368

SEH Biotechnology: Revolutionizing the Global Beverage and Brewing Industry with Cutting-Edge Water and Biotech from Taiwan

TAIPEI, Oct. 25, 2023 /PRNewswire/ -- Taiwan is renowned for its advanced semiconductor technology, and it's also a hub for the development of water technology. SEH Biotechnology Co., Ltd. , based inTaiwan, stands out as the world's only company that ingeniously ...

2023-10-25 18:00 1861

FUTURE INVESTMENT INITIATIVE INSTITUTE RESOLVES TO REMOVE 5.4 TRILLION INVESTMENT GAP IN EMERGING MARKETS

RIYADH, Saudi Arabia, Oct. 25, 2023 /PRNewswire/ -- At the Future Investment Initiative (FII) inRiyadh today, a global summit, leaders and investors have today resolved to tackle ESG shortcomings in the form of a Resolution to Increase ESG Investment in Emerging Markets

2023-10-25 15:46 1984

AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons

TAIPEI, Oct. 25, 2023 /PRNewswire/ -- Medical Japan Tokyo was held grandly from October 11 to 13, gathering medical professionals, manufacturers, medical institutions, and research units from around the world. AMS BioteQ Co., Ltd. made its first appearance in the exhibition and became one of the ...

2023-10-25 13:06 1762

Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development

EAST RUTHERFORD, N.J, Oct. 25, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry has been selected as the winner of the API Development Award, presented at the CPhI Pharma Awards inBarcelona, Spain....

2023-10-25 04:18 2017

Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma

--Industry veteran to lead growth for company's CDMO and pharmaceutical supply divisions, NovaCina and LumaCina-- MIAMI and PERTH, Australia, Oct. 25, 2023 /PRNewswire/ -- Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, announced today thatCyrus K. Mirsaidi is ...

2023-10-24 23:17 1551

Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies

Wolters Kluwer uniquely leverages its expertise to meet market and customer needs, positioning it to capitalize on new growth opportunities and lead in healthcare conversational AI. SAN ANTONIO, Oct. 24, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the conversational artificial inte...

2023-10-24 21:30 1458

OrbiMed Raises $4.3 Billion Across Private Investment Funds

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- OrbiMed, a global healthcare investment firm, is pleased to announce it has raised more than$4.3 billion in commitments for its latest private investment funds, including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit O...

2023-10-24 19:30 1756

Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China

First Amyloid PET Tracer Received Regulatory Approval in China BERLIN and BEIJING, Oct. 24, 2023 /PRNewswire/ -- Life Molecular Imaging (LMI) and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® (with Chinese trade name 欧韦宁®, florbetaben F-18 injection) has received regulatory appr...

2023-10-24 16:00 1530

SID BIO Inc. to Debut at 'in-cosmetics asia 2023,' the World's Largest Cosmetics Ingredients Expo

SEOUL, South Korea, Oct. 24, 2023 /PRNewswire/ -- Korean K-beauty specialist company SID BIO Inc. will make its global market debut at 'in-cosmetics asia 2023,' the world's largest cosmetics ingredients expo, taking place from November 7-9 at the Bangkok International Trade & Exhibition Centre (BI...

2023-10-24 15:50 1457

BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity

Three-part, in-depth analysis of biopharma investments in obesity medications highlights potential impact onpatient population historically faced with limited options LONDON, Oct. 24, 2023 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and ...

2023-10-24 15:00 1430
1 ... 109110111112113114115 ... 580

Week's Top Stories